SEC Comment Letter for Vaxart, Inc. (VXRT) (CIK 0000072444) (VXRT) — Aug 6, 2007

Vaxart, Inc. (VXRT) (CIK 0000072444)
Date: Aug. 6, 2007 · CIK: 0000072444 · Accession: 0000000000-07-038211

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

August 6, 2007

Author

Joel N. Parker

Form

UPLOAD

Company

Vaxart, Inc. (VXRT) (CIK 0000072444)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 August 6, 2007 Leslie Hudson, Ph.D. Chief Executive Officer and President Nabi Biopharmaceuticals 5800 Park of Commer ce Boulevard N.W. Boca Raton, FL 33487

Re: Nabi Biopharmaceuticals Form 10-K for Fiscal Year Ended December 30, 2006 File No. 0-04829

Dear Dr. Hudson:

We have completed our review of your Form 10-K and have no further comments at this time.

S i n c e r e l y ,

Joel N. Parker Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail
Mail Stop 6010
        August 6, 2007

Leslie Hudson, Ph.D.
Chief Executive Officer and President
Nabi Biopharmaceuticals
5800 Park of Commer ce Boulevard N.W.
Boca Raton, FL  33487

Re: Nabi Biopharmaceuticals
 Form 10-K for Fiscal Year Ended December 30, 2006
 File No. 0-04829

Dear Dr. Hudson:

 We have completed our review of your Form 10-K and have no further comments
at this time.

        S i n c e r e l y ,

Joel N. Parker
Branch Chief

SecProbe.io